What Is MOTS-c? The Mitochondrial Peptide for Metabolism and Longevity

Pep-Dose Staff

MOTS-c (Mitochondrial Open Reading Frame of the 12S rRNA type-c) is a 16-amino acid peptide encoded within the mitochondrial genome, making it a unique member of a recently discovered class of signaling molecules called mitochondrial-derived peptides (MDPs). Unlike most peptides synthesized by nuclear genes, MOTS-c is directly produced by the mitochondria and functions as a systemic metabolic regulator with striking parallels to the effects of exercise. It has attracted intense scientific interest for its roles in insulin sensitivity, fat metabolism, cellular stress response, and longevity.

Fast Answer / Executive Summary

MOTS-c is a mitochondria-encoded peptide that acts as a mitohormone, translocating to the nucleus under metabolic stress to regulate gene expression via the AMPK and folate-AICAR pathways. Animal and early human studies show it improves insulin sensitivity, enhances exercise capacity, reduces fat accumulation, and extends healthspan in multiple model organisms. Plasma MOTS-c levels decline with age and are higher in exceptional human longevity cohorts.

Core Concepts and Key Entities

MOTS-c was identified by Changhan David Lee and colleagues at the University of Southern California in 2015. Its sequence is: Ac-MRWQEMGYIFYPRKLR-NH2. It is encoded within a short open reading frame (sORF) of the 12S rRNA gene in the human mitochondrial genome and released into circulation as a functional hormone, acting on distant tissues.

Mechanisms, in one line each:

  • AMPK activation: MOTS-c activates AMP-activated protein kinase (AMPK), the master regulator of cellular energy homeostasis, mimicking the metabolic effects of exercise.
  • Folate-AICAR pathway: MOTS-c inhibits folate and purine metabolism, leading to AICAR accumulation, which in turn activates AMPK independently of AMP/ATP ratios.
  • Insulin sensitization: Improves glucose uptake in skeletal muscle and reduces systemic insulin resistance in diet-induced obesity models.
  • Exercise mimetic: Recapitulates many transcriptional and metabolic effects of physical exercise, including increased fatty acid oxidation and mitochondrial biogenesis.
  • Stress response regulation: Modulates the integrated stress response (ISR), protecting cells during ischemia and metabolic overload.
  • Longevity association: Higher circulating MOTS-c correlates with centenarian longevity; exogenous MOTS-c extends lifespan in male mice on a high-fat diet.

Age-related decline: Plasma MOTS-c concentrations decrease significantly with age in humans. Supercentenarians and their offspring show significantly higher circulating MOTS-c than age-matched controls.

Step-by-Step: How to Work With MOTS-c

Step 1 – Understand the vial sizes and use case

Research-grade MOTS-c is typically available in 5 mg, 10 mg, and 20 mg lyophilized vials. For reconstitution and dosing math, see the MOTS-c 10 mg Dosage Protocol.

Step 2 – Source with documentation

Request a Certificate of Analysis (COA) with HPLC purity (99%+) and mass spec confirmation of the 16-amino acid sequence. Ensure lyophilized product stored at -20 degrees C until use.

Step 3 – Reconstitution math

For a 10 mg vial, add 2.0 mL bacteriostatic water to yield a 5.0 mg/mL stock solution. At 5.0 mg/mL on a U-100 insulin syringe, 1 unit = 50 mcg.

Step 4 – Timing and injection site

Many researchers favor morning administration, ideally 30-60 minutes before exercise, to amplify the exercise-mimetic effects. Subcutaneous injection into the abdomen, thigh, or upper arm; rotate sites systematically.

Step 5 – Cycle and rest

Common protocols: 4-12 weeks on, 4 weeks off. Track fasting glucose, energy levels, and body composition to assess response.

Comparison and Alternatives

Modality Mechanism Primary Benefit Evidence Level Route
MOTS-c AMPK activation, folate-AICAR, nuclear stress response Insulin sensitivity, metabolic health, longevity Preclinical + early human association SC injection (research)
AICAR Direct AMPK activator Exercise mimetic, fat oxidation Preclinical; no human RCTs SC injection or oral
Metformin Mitochondrial complex I inhibition, AMPK T2DM glycemic control, longevity research Robust (decades of RCTs) Oral
Exercise Multiple pathways (AMPK, PGC-1alpha, GLUT4) Insulin sensitivity, cardiovascular, longevity Strongest evidence base N/A

FAQs

1) What is MOTS-c? MOTS-c is a 16-amino acid peptide encoded in the mitochondrial genome that acts as a systemic metabolic hormone. Discovered in 2015, it activates AMPK, improves insulin sensitivity, enhances fat oxidation, and is associated with longer healthspan in both animals and humans.

2) Is MOTS-c the same as exercise in a vial? Not exactly, but the analogy is apt. MOTS-c reproduces many transcriptional signatures of aerobic exercise in skeletal muscle, including AMPK activation, GLUT4 upregulation, and fatty acid oxidation.

3) Does MOTS-c decline with age? Yes. Circulating MOTS-c decreases significantly with age in both animal models and humans. Studies of centenarians and their offspring show markedly higher plasma MOTS-c levels compared to age-matched controls.

4) What is the MOTS-c dosing protocol? In human research contexts, doses of 5-10 mg three times weekly via subcutaneous injection are commonly reported. See the MOTS-c 10 mg Dosage Protocol for full details.

5) Is MOTS-c safe? Long-term human safety data is lacking, as MOTS-c remains a research peptide without FDA approval. Animal studies have not reported significant toxicity. As with all research peptides, quality sourcing and aseptic technique are essential.

6) Can MOTS-c help with type 2 diabetes? Preclinical evidence is compelling. MOTS-c dramatically improved insulin sensitivity and reduced fat mass in diet-induced obese mice. Human RCTs have not yet been conducted.

Evidence Highlights

  • Discovery paper (Lee et al., Cell Metabolism, 2015): MOTS-c identified in human mitochondrial 12S rRNA; shown to regulate insulin sensitivity and prevent diet-induced obesity in mice.
  • Longevity association (Kim et al., PNAS, 2018): Centenarians and their offspring have significantly higher plasma MOTS-c. Links MOTS-c to exceptional human longevity phenotypes.
  • Nuclear translocation (Reynolds et al., Nat Commun, 2021): MOTS-c enters the nucleus during exercise and metabolic stress, directly modulating stress-response gene programs.

Next Steps

Leave a comment